Aarey Drugs Statements
52
Data from Aarey Drugs`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
INR - Indian rupee
Last reporting period :
30 Sep, 2023
New report :
12 Aug, 2024
Reporting period :
Semi-annual
Earnings release date:
—
Expected release date:
11 Nov, 2024
Aarey Drugs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
1 087.87
-51.7 %
100
1 031.77
95.4
56.1
-37.2 %
4.6
—
0
13.635
0.7
32.497
-42.4 %
2.1
23.603
-28.5 %
2.5
-21.61
-2.2
15.323
1.4
17.316
-40.1 %
1.7
-2.22
-0.4
19.538
130.6 %
2.1
0.77
25.298
2 253.53
16.4 %
100
2 164.15
96.9
89.384
44.6 %
3.1
—
0
-1.949
-0.4
56.382
69.3 %
1.7
33.002
15.8 %
1.4
-17.282
-0.6
13.174
0.5
28.894
-7.4 %
1.3
20.323
1.1
8.472
-71 %
0.2
0.332
25.242
1 936
-25.7 %
100
1 874.2
92.7
61.8
-42.1 %
7.3
—
0
10
0.6
33.3
-51.3 %
2.3
28.5
-25.6 %
5.1
-11.4
-0.8
14.1
-1.2
31.2
-25.4 %
3
2.1
0.3
29.2
145.4 %
2.8
1.15
25.25
2 605.2
12.2 %
100
2 498.4
95.3
106.7
7.3 %
4.7
—
0
21.5
0.3
68.4
52 %
3.6
38.3
-29.7 %
1.1
-9.2
-0.4
12.6
0.9
41.8
-28.5 %
1.6
29.8
2.3
11.9
-77.8 %
-0.6
0.4
22.75
2 321.7
36.3 %
100
2 222.2
96
99.4
109.7 %
4
—
0
27.6
1
45
5.6 %
1.8
54.5
1035.4 %
2.2
-10.8
-0.5
14.8
0.6
58.5
52.3 %
2.3
5
0.2
53.5
122.9 %
2.1
2.29
23.35
1 703.3
31.3 %
100
1 655.9
99.2
47.4
-8.5 %
0.8
—
0
20.2
0.4
42.6
28.3 %
1.3
4.8
-74.1 %
-0.5
-9
-0.4
42.7
3.1
38.4
12.9 %
2.2
14.5
1.3
24
-29.4 %
0.9
1.03
23.4
1 297.6
—
100
1 245.9
96.1
51.8
—
3.9
—
0
24.6
1.6
33.2
—
2.6
18.5
—
1.3
-8.8
-0.7
24.3
1.4
34
—
2
—
0
34
—
2
1.45
23.4